IMCR SCHEDULE 13G: SEC filing
Point72 Asset Management, L.P. and affiliated reporting persons
Filed with the SEC on · accession 0000919574-26-007502
IMCR filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.4% by the first close after the filing.
Summary of the filing
Point72 Asset Management, L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 2,720,043 ordinary shares (represented by ADSs) of Immunocore Holdings plc, equal to 5.2% of the class, as of November 6, 2026.
Key details
How IMCR stock reacted
Close before
$30.99
Nov 6, 2026
First close after
+2.39%
$31.73
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMCR?
Click hereFrequently asked questions
What did IMCR file with the SEC on Nov 9, 2026?
IMCR filed a SCHEDULE 13G (SEC filing). Point72 Asset Management, L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 2,720,043 ordinary shares (represented by ADSs) of Immunocore Holdings plc, equal to 5.2% of the class, as of November 6, 2026.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did IMCR stock react to this filing?
IMCR closed at $30.99 before the filing and $31.73 on Nov 9, 2026 (+2.39%).
Other IMCR SEC filings
- 10-Q · SEC filingNov 6, 2026
- 8-K · SEC filingNov 6, 2026
- SCHEDULE 13G/A · SEC filingOct 7, 2026
- 8-K · Fda approvalSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 6, 2026
- 8-K · SEC filingMay 27, 2026
- 10-Q · SEC filingMay 6, 2026
Get alerts when IMCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days